Background: Alzheimer's disease (AD) is a progressive neurodegenerative disease that causes the decline of some cognitive impairments. The present study aimed to identify the corpus callosum (CC) radiomic features related to the diagnosis of AD and build and evaluate a classification model.Methods: Radiomics analysis was applied to the three-dimensional T1-weighted magnetization-prepared rapid gradient echo (MPRAGE) images of 78 patients with AD and 44 healthy controls (HC). The CC, in each subject, was segmented manually and 385 features were obtained after calculation. Then, the feature selection were carried out. The logistic regression model was constructed and evaluated according to identified features. Thus, the model can be used for distinguishing the AD from HC subjects.Results: Eleven features were selected from the three-dimensional T1-weighted MPRAGE images using the LASSO model, following which, the logistic regression model was constructed. The area under the receiver operating characteristic curve values (AUC), sensitivity, specificity, accuracy, precision, and positive and negative predictive values were 0.720, 0.792, 0.500, 0.684, 0.731, 0.731, and 0.583, respectively.Conclusion: The results demonstrated the potential of CC texture features as a biomarker for the diagnosis of AD. This is the first study showing that the radiomics model based on machine learning was a valuable method for the diagnosis of AD.

In patients with AD, the PCC in the DMN shows disorders in receiving and transmitting information, and these abnormalities are directional.

Synchronous liver metastasis (SLM) remains a major challenge for rectal cancer. Early detection of SLM is a key factor to improve the survival rate of rectal cancer. In this radiomics study, we predicted the SLM based on the radiomics of primary rectal cancer. A total of 328 radiomics features were extracted from the T2WI images of 194 patients. The least absolute shrinkage and selection operator (LASSO) regression was used to reduce the feature dimension and to construct the radiomics signature. after LASSO, principal component analysis (PCA) was used to sort the features of the surplus characteristics, and selected the features of the total contribution of 85%. Then the prediction model was built by linear regression, and the decision curve analysis was used to judge the net benefit of LASSO and PCA. In addition, we used two independent cohorts for training (n = 135) and validation (n = 159). We found that the model based on LASSO dimensionality construction had the maximum net benefit (in the training set (AUC [95% confidence interval], 0.857 [0.787–0.912]) and in the validation set (0.834 [0.714–0.918]). The radiomics nomogram combined with clinical risk factors and LASSO features showed a good predictive performance in the training set (0.921 [0.862–0.961]) and validation set (0.912 [0.809–0.97]). Our study indicated that radiomics based on primary rectal cancer could provide a non-invasive way to predict the risk of SLM in clinical practice.